J
Jean L. Freeman
Researcher at University of Texas Medical Branch
Publications - 50
Citations - 4376
Jean L. Freeman is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Population & Breast cancer. The author has an hindex of 29, co-authored 50 publications receiving 4105 citations. Previous affiliations of Jean L. Freeman include National Institutes of Health & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Regional Variation in Stroke Rehabilitation Outcomes
Timothy A. Reistetter,Amol Karmarkar,James E. Graham,Karl Eschbach,Yong Fang Kuo,Carl V. Granger,Jean L. Freeman,Kenneth J. Ottenbacher +7 more
TL;DR: Rehabilitation outcomes for persons with stroke varied across CMS regions, with substantial variation in discharge destination and LOS remained after adjusting for demographic and clinical characteristics.
Journal ArticleDOI
Late gastrointestinal toxicity after radiation for prostate cancer.
TL;DR: Rates and predictors of late, lower gastrointestinal toxicity after radiation therapy in a population‐based cohort of older men with prostate cancer are determined.
Journal ArticleDOI
Variation in false-positive rates of mammography reading among 1067 radiologists: a population-based assessment
TL;DR: Radiologists varied greatly in accuracy of mammography reading and female and more recently trained radiologists had higher false-positive rates than male radiologists, especially unmeasured radiologist factors.
Journal ArticleDOI
The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist
TL;DR: Chemotherapy improves survival for patients with stage III colon cancer, but some older patients with lymph node‐positive colon cancer do not see a medical oncologist and, thus, do not receive adjuvant chemotherapy.
Journal ArticleDOI
Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.
Mukaila A. Raji,Lynsey P. Tamborello,Yong Fang Kuo,Hyunsu Ju,Jean L. Freeman,Dong Zhang,Sharon H. Giordano,James S. Goodwin +7 more
TL;DR: Concerns about post-chemotherapy dementia should not be a major factor in determining type of adjuvant chemotherapy regimen to prescribe for older women with breast cancer, as there was no significant association between types of chemotherapy agents and risk of subsequent dementia diagnoses.